Recent Articles

Open access

ISSN: 2352-3042
CN: 50-1221/R
p-ISSN: 2352-4820

Enhancing ovarian cancer immunotherapy through TAGLN2-modified CAR-T cells

Transcriptional circuits of the glioma microenvironment: FOSL2 as a master regulator of the pathological niche

A novel causative LMNA variant in acrogeria syndrome and literature review of genotype–phenotype correlations

Splice rescue of protein-truncating variants is associated with reduced selection pressure and attenuated disease phenotypes

Ginsenoside Rg1 attenuates mitochondrial dysfunction in bleomycin-induced pulmonary fibrosis by inhibiting Nrf2/Sirt3 pathways

Robust prediction of response to growth hormone therapy by five PBMC-based transcripts

TfR1 deficiency beyond combined immunodeficiency. Pivotal role of mitochondrial function and iron-sulfur cluster biogenesis in disease pathogenesis

Clinical and iPSC-based characterization of the HNF1A p.T82M variant

ENO1 as a potential tumor prognostic marker promotes the proliferation, invasion, and metastasis of breast cancer cells

Ionizing radiation induces senescence of dermal papilla cells through inhibiting the FOXM1–KIF20A pathway

Construction and characterization of a cardiac organoid ARVC disease model with its application in gene therapy targeting PKP2

The DDIT4L-TOM40-ATP5A pathway suppresses glioblastoma oncogenesis

VCP at the crossroads of UPS and autophagy in cancer

Proteostasis is maintained by the coordinated action of the ubiquitin–proteasome system (UPS) and autophagy–lysosome pathways. Valosin-containing protein (VCP/p97), an AAA + unfoldase, sits at its intersection...

ONC201/dordaviprone for H3 K27M-mutant tumors: Discovery, mechanisms, therapeutic potential, and future directions

ONC201 (dordaviprone) has recently received accelerated approval for the treatment of recurrent H3 K27M–mutant diffuse midline glioma. Originally identified as TRAIL-inducing compound 10 (TIC10), ONC201...

Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights

Metabolic reprogramming is an important factor contributing to tumor medication resistance and recurrence in cancer cells. There is ample proof that metabolic remodeling is vital in colorectal cancer’s...

Necroptosis-related diseases are regulated by the unfolded protein response during endoplasmic reticulum stress

In recent years, research has highlighted that necroptosis plays a significant role in various diseases, suggesting that studying the pathways of necroptosis may offer novel avenues for developing treatments...

Lactylation: Metabolic epigenetic regulation and cell death mechanisms in myocardial ischemia‒reperfusion injury

One important pathogenic process that contributes to subsequent damage after myocardial infarction (MI) revascularization is myocardial ischemia/reperfusion injury (MI/RI). Its underlying mechanisms...

Functions of exosome-derived noncoding RNA-encoded polypeptides/proteins in human diseases

Exosomes are nanoscale vesicles that are ubiquitously present in biological fluids and exhibit remarkable stability, carrying a diverse array of biologically active molecules, including various RNAs,...

Rewiring redox defense: Nrf2-driven antioxidant signaling as a gateway to programmed cell death activation in colorectal cancer

Nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of antioxidant and phase II detoxification genes, plays a dual role in colorectal cancer (CRC) progression by maintaining redox...

Influence of oncogenic drivers and signaling pathways on immune checkpoint inhibitor efficacy in NSCLC

Non-small cell lung cancer (NSCLC) is characterized by intricate genetic modifications and mechanisms that allow it to evade immune detection, which complicates the pursuit of lasting therapeutic responses....

Autosomal dominant gain-of-function mutations in LCP1 cause a syndromic neutropenia and immunodeficiency

Actin cytoskeleton defects underlie immuno-actinopathies. We identified three patients with heterozygous LCP1 gain-of-function mutations (L362F, A365D) causing activated LCP1-associated immunodeficiency...

Efineptakin alfa (NT-I7) improves overall survival and induces immune niches in murine tumors

Tertiary lymphoid structures (TLSs) are emerging as good predictive biomarkers of response to cancer immunotherapy. However, therapeutic strategies to induce these structures are currently limited....

Steatotic liver-derived extracellular vesicles deliver ACSL4 to potentiate hepatic ischemia–reperfusion injury by orchestrating a ferroptosis-mitochondrial apoptosis cascade

Steatotic liver grafts exhibit heightened susceptibility to hepatic ischemia–reperfusion injury (HIRI), contributing to poor outcomes in liver transplantation; however, the underling mechanisms remain...

PINK1 deficiency exacerbates age-related bone loss in association with enhanced inflammatory adipocyte differentiation

Age-related bone loss contributes to frailty, fractures, and increased mortality in the elderly, yet current osteoporosis treatments have limited long-term efficacy. Mitochondrial dysfunction is a hallmark...

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.